Friday, May 22, 2026
spot_img

Don't Miss

Funding

Conexeu Sciences commences trading on Nasdaq under ticker symbol “CNXU”

0
Conexeu Sciences Inc., a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol “CNXU.”...

$200M merger of Dominion and BellaMia creates new laser robotic leader

Conexeu Sciences advances 3D Biofabricated Matrix to move breast reconstruction beyond implants

Dr. Jason Emer launches EmerGPT

Koru Pharma announces strategic partnership with LYFE Capital

Clinical Trials

Clinical Trials

Lumenis Aesthetics showcases new clinical data across skin and hair loss indications

0
Lumenis Be Ltd., a leading energy-based medical device company for aesthetic and eye care applications, announced new clinical data from its portfolio of industry-leading...
Clinical Trials

Veradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302’ Clinical Trial

0
Veradermics, Incorporated, a dermatologist-founded, late-stage biopharmaceutical company focused on developing innovative therapeutics for pattern hair loss, announced positive topline results from Part A of...

Cutia Therapeutics’ Botox Rival meets Phase III goals in China

Obagi Medical shares new clinical data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum

VISTA Trial validates noninvasive tool for skin feature identification

CollPlant’s rhCollagen-based BioInk demonstrates strong performance compared to Matrigel

EVENTS

Funding

Funding

Conexeu Sciences commences trading on Nasdaq under ticker symbol “CNXU”

0
Conexeu Sciences Inc., a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol “CNXU.”...

W-Wellness secures strategic funding

Plcoskin secures $2 Million from Highlight Capital

Galderma welcomes increased equity investment from L’Oréal

Charterhouse Capital Partners announces investment in Winback

- Advertisement -

Featured

Latest Reviews

Funding

Conexeu Sciences commences trading on Nasdaq under ticker symbol “CNXU”

0
Conexeu Sciences Inc., a biotechnology company advancing tissue regeneration, announced it has officially commenced trading on the Nasdaq today under the ticker symbol “CNXU.”...

$200M merger of Dominion and BellaMia creates new laser robotic leader

Conexeu Sciences advances 3D Biofabricated Matrix to move breast reconstruction beyond implants

Mergers & Acquisitions

$200M merger of Dominion and BellaMia creates new laser robotic leader

0
Dominion Aesthetic Technologies, Inc. and BellaMia Technologies, Inc. announced they have completed a strategic merger. Dominion is the creator of EON®, the leader in...

Koru Pharma announces strategic partnership with LYFE Capital

0
Koru Pharma is pleased to announce a strategic partnership with LYFE Capital, a global healthcare investment firm. As part of this agreement, LYFE Capital...

Senté announces strategic partnership and equity financing

0
Senté, a leader in medical-grade skincare innovation, announced the successful closing of a strategic partnership and equity financing. This milestone positions the company to...

Phiusion Labs announces a strategic distribution partnership with Proteos Biotech S.L.

0
Phiusion Labs Inc. announced a strategic partnership with Proteos Biotech S.L.. This partnership will facilitate the distribution of the PBSerum® product portfolio across the...

Hugel to enter ECM-based injectable market with aesthetic portfolio expansion

0
Hugel Inc., a leading global medical aesthetics company publicly traded in South Korea, has accelerated its growth strategy by adding an extracellular matrix (ECM)-based...
- Advertisement -
Advertismentspot_imgspot_img
Advertismentspot_imgspot_img

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Driving Growth in Aesthetics Globally

Over the past decade, we have successfully sourced talent for 40+ Medical Aesthetics companies across 20+ countries, completing over 350+ searches. Leveraging our extensive network and deep industry expertise, we have supported businesses at various growth stages, driving innovation in the sector.

Contact us: contact@ValuraNova.com